Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 296 (RNA5SP296) is a pseudogene related to the functional 5S ribosomal RNA gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations, lack of regulatory elements, or improper transcription/processing[2][4]. The parent 5S rRNA is a ~120 nucleotide, non-coding RNA essential for ribosome structure and function[3][1]. Unlike functional 5S rRNA genes, 5S rRNA pseudogenes like RNA5SP296 are not known to produce active RNA molecules incorporated into the ribosome or used in protein synthesis. Such pseudogenes usually do not encode proteins or functional RNAs, and are not considered therapeutic targets, receptors, or enzymes. In rare cases, expressed pseudogenes can regulate related genes at the RNA level (for example, through miRNA sponging, producing endogenous siRNAs, or affecting epigenetic regulation), but there is no evidence of such a function for RNA5SP296[4]. This pseudogene is listed as non-functional and is cataloged in gene databases as an rRNA pseudogene. 5S rRNA itself is non-coding, critical for ribosome assembly, and mediates allosteric communication within the ribosome[1][3]. Pseudogenes (like RNA5SP296) are primarily genomic fossils of functional genes, not actively involved in established cellular pathways[2][4]. There is nothing to suggest that this specific pseudogene is used as a drug target, biomarker, or confers safety concerns in therapeutics. As an rRNA pseudogene, it lacks the features that define a molecular target in pharmacology or biomedicine.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 296 (RNA5SP296).